Literature DB >> 31065156

National Survey Exploring Drug Screening in Pharmacy Programs.

Patricia L Darbishire1,2, Patricia S Devine3, Alexa J Proctor1, Wesley J Horner1, Emily M Hoffman3, Carol A Ott1, David G Fuentes2,4, Jeremy Hughes4, Priya B Patel1.   

Abstract

Objective. To explore drug screening programs, including requirements, policies, and procedures among pharmacy programs; frequency of drug-related incidents; and types of substances misused by pharmacy students. Methods. IRB-approved web-based and paper surveys were sent to pharmacy deans, experiential education faculty, and student affairs personnel at 135 US ACPE-accredited and candidate status programs. Descriptive statistics and chi-square test were used to analyze the data, identify relationships and draw conclusions. Results. Administrators from 98 programs responded (73% response rate). Sixty-one percent reported implementing a urine drug screen requirement for students, with a 10-panel screen as the most common required screen (72%). Ninety-three percent of programs require students to pay for the screen, with costs averaging $42 per screen. Programs reported an average of 2.2 substance-related events per 100 students annually, with alcohol, marijuana, amphetamines, opioids and benzodiazepines most commonly involved. Schools that do not screen reported twice as many incidents as those that screen. Conclusion. A drug screening program can deter pharmacy students from inappropriate substance use. The results from this study can assist pharmacy administrators in evaluating the need to institute or enhance a drug screening program at their school or college of pharmacy.

Entities:  

Keywords:  drug screen; drug testing; experiential education; pharmacy policies; substance abuse

Mesh:

Year:  2019        PMID: 31065156      PMCID: PMC6498202          DOI: 10.5688/ajpe6576

Source DB:  PubMed          Journal:  Am J Pharm Educ        ISSN: 0002-9459            Impact factor:   2.047


  23 in total

1.  Workplace drug testing, different matrices different objectives.

Authors:  Lolita M Tsanaclis; John F C Wicks; Alice A M Chasin
Journal:  Drug Test Anal       Date:  2012-02       Impact factor: 3.345

2.  Student drug testing in nursing education.

Authors:  Valerie T Cotter; Mary Ellen Smith Glasgow
Journal:  J Prof Nurs       Date:  2012 May-Jun       Impact factor: 2.104

3.  The addicts among us.

Authors:  Jeffrey N Baldwin
Journal:  Am J Pharm Educ       Date:  2009-11-12       Impact factor: 2.047

4.  Attitudes of matriculating first-year pharmacy students toward a mandatory, random drug-screening program.

Authors:  Maggee Oliver; Marshall E Cates; Michael D Hogue; Susan P Alverson; Thomas W Woolley
Journal:  Am J Pharm Educ       Date:  2012-11-12       Impact factor: 2.047

5.  Experience with a drug screening program at a school of pharmacy.

Authors:  Marshall E Cates; Michael D Hogue
Journal:  J Am Coll Health       Date:  2012

Review 6.  ASHP Statement on the Pharmacist's Role in Substance Abuse Prevention, Education, and Assistance.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  2016-05-01       Impact factor: 2.637

7.  Use and abuse of controlled substances by pharmacists and pharmacy students.

Authors:  W E McAuliffe; S L Santangelo; J Gingras; M Rohman; A Sobol; E Magnuson
Journal:  Am J Hosp Pharm       Date:  1987-02

Review 8.  Impaired healthcare professional.

Authors:  Marie R Baldisseri
Journal:  Crit Care Med       Date:  2007-02       Impact factor: 7.598

9.  Assessment of alcohol and other drug use behaviors in health professions students.

Authors:  Jeffrey N Baldwin; David M Scott; Sangeeta Agrawal; Jean K Bartek; R Ellen Davis-Hall; Thomas P Reardon; Edward M DeSimone
Journal:  Subst Abus       Date:  2006-09       Impact factor: 3.716

10.  Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots.

Authors:  Sean Esteban McCabe; Brady T West; Christian J Teter; Carol J Boyd
Journal:  Addict Behav       Date:  2014-03-12       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.